1. Home
  2. BODI vs NSRX Comparison

BODI vs NSRX Comparison

Compare BODI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

N/A

Current Price

$4.75

Market Cap

45.8M

Sector

Industrials

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$3.82

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BODI
NSRX
Founded
1998
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.8M
38.9M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
BODI
NSRX
Price
$4.75
$3.82
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$17.00
★ $19.67
AVG Volume (30 Days)
★ 23.4K
14.8K
Earning Date
11-09-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 96.10
N/A
EPS
★ 0.47
N/A
Revenue
★ $251,727,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$10.02
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.05
$1.98
52 Week High
$16.87
$9.50

Technical Indicators

Market Signals
Indicator
BODI
NSRX
Relative Strength Index (RSI) 29.31 59.59
Support Level N/A $2.97
Resistance Level $11.36 $4.49
Average True Range (ATR) 0.25 0.28
MACD 0.10 0.02
Stochastic Oscillator 23.47 81.70

Price Performance

Historical Comparison
BODI
NSRX

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: